Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Jan;27(1):13–18. doi: 10.1111/j.1365-2125.1989.tb05329.x

The renal effects of atrial natriuretic peptide in man are not attenuated by (+)-sulpiride.

S Freestone 1, T M MacDonald 1, R F Jeffrey 1, J Brown 1, M R Lee 1
PMCID: PMC1379699  PMID: 2523227

Abstract

1. Human alpha atrial natriuretic peptide (ANP) was infused intravenously for 1 h in eight healthy salt-replete men on two occasions, with and without pretreatment with (+)-sulpiride. 2. ANP increased sodium excretion and urine flow rate but did not alter blood pressure or plasma renin activity. 3. (+)-sulpiride had no significant effect on baseline creatinine clearance, sodium excretion or urine flow rate and did not alter the increases in these parameters with ANP. 4. It is unlikely that the renal effects of ANP are mediated by dopamine DA1-receptors in man.

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL. J Pharmacol Exp Ther. 1964 Sep;145:326–336. [PubMed] [Google Scholar]
  2. Anderson J. V., Donckier J., Payne N. N., Beacham J., Slater J. D., Bloom S. R. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci (Lond) 1987 Mar;72(3):305–312. doi: 10.1042/cs0720305. [DOI] [PubMed] [Google Scholar]
  3. Anderson J., Struthers A., Christofides N., Bloom S. Atrial natriuretic peptide: an endogenous factor enhancing sodium excretion in man. Clin Sci (Lond) 1986 Apr;70(4):327–331. doi: 10.1042/cs0700327. [DOI] [PubMed] [Google Scholar]
  4. Ball S. G., Lee M. R. The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone? Br J Clin Pharmacol. 1977 Apr;4(2):115–119. doi: 10.1111/j.1365-2125.1977.tb00681.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ball S. G., Oats N. S., Lee M. R. Urinary dopamine in man and rat: effects of inorganic salts on dopamine excretion. Clin Sci Mol Med. 1978 Aug;55(2):167–173. doi: 10.1042/cs0550167. [DOI] [PubMed] [Google Scholar]
  6. Bass A. S., Robie N. W. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney. J Pharmacol Exp Ther. 1984 Apr;229(1):67–71. [PubMed] [Google Scholar]
  7. Goldberg L. I., Glock D., Kohli J. D., Barnett A. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension. 1984 Mar-Apr;6(2 Pt 2):I25–I30. doi: 10.1161/01.hyp.6.2_pt_2.i25. [DOI] [PubMed] [Google Scholar]
  8. Gutkowska J., Thibault G., Januszewicz P., Cantin M., Genest J. Direct radioimmunoassay of atrial natriuretic factor. Biochem Biophys Res Commun. 1984 Jul 31;122(2):593–601. doi: 10.1016/s0006-291x(84)80074-1. [DOI] [PubMed] [Google Scholar]
  9. HARVEY R. B., BROTHERS A. J. Renal extraction of para-aminohippurate and creatinine measured by continuous in vivo sampling of arterial and renal-vein blood. Ann N Y Acad Sci. 1962 Oct 31;102:46–54. doi: 10.1111/j.1749-6632.1962.tb13624.x. [DOI] [PubMed] [Google Scholar]
  10. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  11. Jeffrey R. F., Macdonald T. M., Rutter M., Freestone S., Brown J., Samson R. R., Lee M. R. The effect of intravenous frusemide on urine dopamine in normal volunteers: studies with indomethacin and carbidopa. Clin Sci (Lond) 1987 Aug;73(2):151–157. doi: 10.1042/cs0730151. [DOI] [PubMed] [Google Scholar]
  12. Lang R. E., Unger T., Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens. 1987 Jun;5(3):255–271. doi: 10.1097/00004872-198706000-00001. [DOI] [PubMed] [Google Scholar]
  13. MacDonald T. M., Jeffrey R. F., Freestone S., Lee M. R. (+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man. Br J Clin Pharmacol. 1988 Feb;25(2):203–212. doi: 10.1111/j.1365-2125.1988.tb03292.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marin-Grez M., Briggs J. P., Schubert G., Schnermann J. Dopamine receptor antagonists inhibit the natriuretic response to atrial natriuretic factor (ANF). Life Sci. 1985 Jun 3;36(22):2171–2176. doi: 10.1016/0024-3205(85)90314-5. [DOI] [PubMed] [Google Scholar]
  15. Nicolas P., Fauvelle F., Ennachachibi A., Merdjan H., Petitjean O. Improved determination of sulpiride in plasma by ion-pair liquid chromatography with fluorescence detection. J Chromatogr. 1986 Sep 5;381(2):393–400. doi: 10.1016/s0378-4347(00)83605-1. [DOI] [PubMed] [Google Scholar]
  16. Pettersson A., Hedner J., Hedner T. The diuretic effect of atrial natriuretic peptide (ANP) is dependent on dopaminergic activation. Acta Physiol Scand. 1986 Apr;126(4):619–621. doi: 10.1111/j.1748-1716.1986.tb07865.x. [DOI] [PubMed] [Google Scholar]
  17. Richards A. M., Nicholls M. G., Ikram H., Webster M. W., Yandle T. G., Espiner E. A. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet. 1985 Mar 9;1(8428):545–549. doi: 10.1016/s0140-6736(85)91207-3. [DOI] [PubMed] [Google Scholar]
  18. Struthers A. D., Anderson J. V., Causon R. C., Christofides N. D., Bloom S. R. The effect of human atrial natriuretic peptide on urinary sodium and urinary dopamine excretion in man. J Hypertens Suppl. 1985 Dec;3(3):S315–S317. [PubMed] [Google Scholar]
  19. Webb R. L., Della Puca R., Manniello J., Robson R. D., Zimmerman M. B., Ghai R. D. Dopaminergic mediation of the diuretic and natriuretic effects of ANF in the rat. Life Sci. 1986 Jun 23;38(25):2319–2327. doi: 10.1016/0024-3205(86)90639-9. [DOI] [PubMed] [Google Scholar]
  20. Weidmann P., Hellmueller B., Uehlinger D. E., Lang R. E., Gnaedinger M. P., Hasler L., Shaw S., Bachmann C. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab. 1986 May;62(5):1027–1036. doi: 10.1210/jcem-62-5-1027. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES